Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» IPX066
IPX066
Impax Rytary FDA Action Date Extended by Three Months
Yahoo/Zacks.com
Thu, 09/18/14 - 07:37 pm
Impax
Rytary
FDA
IPX066
GSK Sets Stage for Big Late-Stage Drug Events, Potential Blockbusters
Motley Fool
Wed, 11/2/11 - 11:14 am
GSK
Relovair
IPX066
Dolutegravir
Insider Buying On Impax After Parkinson's Drug Study Results
Seeking Alpha
Sat, 08/27/11 - 01:07 pm
Impax Labs
Parkinson's Disease
IPX066
GSK
Biotech Clinical Trials Update
Seeking Alpha
Thu, 08/25/11 - 11:48 am
IPX066
Treprostinil
United Therapeutics
Impax
GSK
clinical trials
Impax jumps 10% on Parkinson's study
Marketwatch
Mon, 08/15/11 - 06:29 pm
Impax
Parkinson's Disease
IPX066
GSK
GlaxoSmithKline: Second PhIII Parkinson's drug study turns in winning data
Fierce Biotech
Mon, 08/15/11 - 10:28 am
GSK
Parkinson's Disease
IPX066
Impax
Glaxo drug for Parkinson’s disease works well in study
Bizjournals.com
Mon, 03/14/11 - 10:13 pm
Parkinson's Disease
IPX066
Impax
GSK